Kala Bio KALA
NASDAQ KALA
$0.16 +0.01 (+6.67%)
At close: Nov 6, 2026 · 4:00 PM EST

Kala Bio (KALA) Long-Term Debt Issuances (2018)

Updated

Kala Bio (KALA) reported Long-Term Debt Issuances of $77.78 million for FY2021.

Analysis

Kala Bio (KALA) Long-Term Debt Issuances (2018) Analysis & Trends

Dating back to FY2015, Kala Bio's Long-Term Debt Issuances record includes 5 years.

  • Long-Term Debt Issuances has a five-year compound annual growth rate of 125.5% (FY2016 to FY2021).
  • The FY2021 figure ranks as the highest annual Long-Term Debt Issuances in data going back to FY2015.
  • According to Business Quant data, Long-Term Debt Issuances came in at $71.93 million in FY2018 (+619.3%) and $10 million in FY2017 (+650.2%).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) LT Debt Issuance (Qtr)
1 Eli Lilly 1,224.11 Bn 1,197.72 Bn 20.46 Bn -
2 Johnson & Johnson 665.34 Bn 585.20 Bn 17.30 Bn -
3 AbbVie 515.72 Bn 483.73 Bn 13.12 Bn 9.98 Bn
4 Merck 362.64 Bn 325.58 Bn 13.19 Bn -
5 Novartis Ag 315.51 Bn 288.75 Bn - -
6 Astrazeneca 289.26 Bn 263.15 Bn 13.26 Bn -
7 Amgen 249.20 Bn 200.85 Bn 7.58 Bn -
8 Gilead Sciences 207.48 Bn 182.59 Bn 6.73 Bn -
9 Pfizer 167.49 Bn 114.85 Bn 12.56 Bn -
10 Kala Bio 2.38 Mn -42.27 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2018 69.20 Mn
Mar 31, 2018 2.73 Mn
API Access

Kala Bio Long-Term Debt Issuances API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=long-term-debt-issuances&ticker=KALA&period=max&api_key=YOUR_API_KEY